Iambic AI: Redefining Drug Discovery by 2026
Iambic's new AI platform aims to accelerate drug development. Learn how it uses multimodal data to deliver candidates in 12-18 months.
CRISPR gene-editing in agriculture is set for $50B+ investment by 2030. Learn why it matters for crops, food, and future growth opportunities.
Iambic IPO: Biotech’s 2026 Valuation Shift